Riding on biosimilar sales, Biocon Q4 profit up 64% at Rs 214 crore

Riding on biosimilar sales, Biocon Q4 profit up 64% at Rs 214 crore Total revenue during the quarter grew by 26 percent to Rs 1,557 crore.

No comments:

Post a Comment